Delivery Order SPE2DB24D2100-SPE2DB25FBECF

Award Date 5/12/25
Potential Completion Date 6/3/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,676.12, is for the supply of 4568039004 INGREZZA 40 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 16, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,553.31, is for the delivery of 4565242920 INGREZZA 40 MG CAPSULE 30S. The contract is a firm fixed-price delivery order with an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,676.12 contract is for the delivery of 4,568,077,962 units of the pharmaceutical product INGREZZA 40 MG CAPSULE 30S. The contract has an ultimate completion date of May 20, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp holds a substantial...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INGREZZA 40 MG CAPSULE 30S, a specialty medication, with a ceiling value of $6,239.10 and a completion date of June 2, 2023. The contract is a firm fixed-price delivery order and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $3,553.31, is for the supply of INGREZZA 40 MG CAPSULE 30S, a prescription medication. The contract has a firm fixed price pricing type and an ultimate completion date of August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,027.70, is for the delivery of INGREZZA 80 MG CAPSULE 30S, a medication used to treat a neurological condition. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 80 MG CAPSULE 30S. The order has a firm fixed price of $3,714.98 and a completion date of February 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of INGREZZA 80 MG CAPSULE 30S, a pharmaceutical product. The contract has a ceiling value of $3,893.15 and a completion date of September 25, 2024. The contract is a Firm Fixed Price contract type. This order is part of a larger Indefinite Delivery Contract (IDC) that DLA Troop Support Medical has with AmerisourceBergen, valued at up to $999,999,999 through December 2025,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,049.61 firm fixed-price contract is for the supply of INGREZZA 60 MG CAPSULE 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025 and was awarded on December 26, 2024. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to the pharmaceutical distributor Amerisourcebergen Drug Corp for the supply of INGREZZA 80 MG CAPSULE 30S. The firm-fixed-price contract has a ceiling value of $3,893.15 and an ultimate completion date of September 3, 2024. This appears to be a component of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBECF
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INGREZZA 40 MG CAPSULE 30S. The contract has a firm fixed price of $3,676.12 and a completion date of June 3, 2025. The contract is not set aside and was awarded on May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is part of the company's broader role as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 8/17/25, 1:10 AM